![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| Advisory-HTAC-Preliminary-List-of-Prioritized-Topics-V6.pdf | 2024-02-28 14:04 | 2.0M | |
| Advisory-HTAC-Preliminary-Recommendation-on-Zoledronic-Acid.pdf | 2024-02-28 15:10 | 387K | |
| Advisory-re_GUIDELINES-ON-THE-PROCESS-AND-METHODS-FOR-THE-SELECTION-OF-MEDICAL-DEVICES-FOR-PEMLD.pdf | 2024-02-28 13:25 | 739K | |
| Advisory_Draft-Guidelines-on-the-Application-of-Philippine-Social-Values-on-HTA-For-Comments-Until-05-October-2022-pages-2.pdf | 2024-02-28 13:15 | 620K | |
| DC-2022-0486-Non-incluion-of-eribulin-for-mSTS-in-the-PNF.pdf | 2024-02-28 13:18 | 165K | |
| FOR-DISSEMINATION-DM-Methodology-of-PEMDL.pdf | 2024-02-28 13:26 | 261K | |
| For-dissemination-DRAFT-HTA-SOCIAL-VALUES-GUIDE-DRAFT.pdf | 2024-02-28 13:16 | 309K | |
| HTA-Weekly-Evidence-Report-10-to-16-September-2022.pdf | 2024-02-27 17:03 | 492K | |
| HTA-Weekly-Evidence-Report-17-to-23-September-2022.pdf | 2024-02-27 17:02 | 558K | |
| dc2022-0291-A.pdf | 2024-02-28 13:03 | 115K | |
| dc2022-0491.pdf | 2024-02-28 13:07 | 166K | |
| dm2022-0379.pdf | 2024-02-28 15:27 | 120K | |